Literature DB >> 26340113

Cannabinoid receptor with an 'identity crisis' gets a second look.

Nala Rogers.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26340113     DOI： 10.1038/nm0915-966

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

Review 1.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 2.  CB2 receptors as new therapeutic targets for liver diseases.

Authors:  S Lotersztajn; F Teixeira-Clerc; B Julien; V Deveaux; Y Ichigotani; S Manin; J Tran-Van-Nhieu; M Karsak; A Zimmer; A Mallat
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

Review 3.  Cannabinoid receptors: nomenclature and pharmacological principles.

Authors:  Linda Console-Bram; Jahan Marcu; Mary E Abood
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-28       Impact factor: 5.067

4.  Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB₂ receptor.

Authors:  Jean-Ha Baek; Cynthia L Darlington; Paul F Smith; John C Ashton
Journal:  J Neurosci Methods       Date:  2013-04-09       Impact factor: 2.390

Review 5.  CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?

Authors:  Amey Dhopeshwarkar; Ken Mackie
Journal:  Mol Pharmacol       Date:  2014-08-08       Impact factor: 4.436

6.  A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction.

Authors:  Thor Ostenfeld; Jeffrey Price; Massimo Albanese; Jonathan Bullman; Fiona Guillard; Ingo Meyer; Rachel Leeson; Cristina Costantin; Luigi Ziviani; Pier Francesco Nocini; Stefano Milleri
Journal:  Clin J Pain       Date:  2011-10       Impact factor: 3.442

7.  Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor.

Authors:  Roger Slavik; Uwe Grether; Adrienne Müller Herde; Luca Gobbi; Jürgen Fingerle; Christoph Ullmer; Stefanie D Krämer; Roger Schibli; Linjing Mu; Simon M Ametamey
Journal:  J Med Chem       Date:  2015-05-14       Impact factor: 7.446

8.  Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.

Authors:  Cristina Benito; Estefanía Núñez; Rosa M Tolón; Erica J Carrier; Alberto Rábano; Cecilia J Hillard; Julián Romero
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

9.  Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis.

Authors:  Anna Maria Malfitano; Chiara Laezza; Alba D'Alessandro; Claudio Procaccini; Giuseppe Saccomanni; Tiziano Tuccinardi; Clementina Manera; Marco Macchia; Giuseppe Matarese; Patrizia Gazzerro; Maurizio Bifulco
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

10.  Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.

Authors:  Federica Barutta; Fabiana Piscitelli; Silvia Pinach; Graziella Bruno; Roberto Gambino; Maria Pia Rastaldi; Gennaro Salvidio; Vincenzo Di Marzo; Paolo Cavallo Perin; Gabriella Gruden
Journal:  Diabetes       Date:  2011-08-01       Impact factor: 9.461
View more
  11 in total

Review 1.  An overview of the cannabinoid type 2 receptor system and its therapeutic potential.

Authors:  Bihua Bie; Jiang Wu; Joseph F Foss; Mohamed Naguib
Journal:  Curr Opin Anaesthesiol       Date:  2018-08       Impact factor: 2.706

2.  Development of Highly Affine and Selective Fluorinated Cannabinoid Type 2 Receptor Ligands.

Authors:  Rareş-Petru Moldovan; Kristin Hausmann; Winnie Deuther-Conrad; Peter Brust
Journal:  ACS Med Chem Lett       Date:  2017-04-28       Impact factor: 4.345

Review 3.  Neuroinflammation, Early-Life Adversity, and Brain Development.

Authors:  Susan L Andersen
Journal:  Harv Rev Psychiatry       Date:  2022 Jan-Feb 01       Impact factor: 3.732

4.  The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.

Authors:  Eric W Bow; John M Rimoldi
Journal:  Perspect Medicin Chem       Date:  2016-06-28

5.  Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference.

Authors:  Qing-Rong Liu; Ana Canseco-Alba; Hai-Ying Zhang; Patricia Tagliaferro; Monika Chung; Eugene Dennis; Branden Sanabria; Norman Schanz; Joao Carlos Escosteguy-Neto; Hiroki Ishiguro; Zhicheng Lin; Susan Sgro; Claire M Leonard; Jair Guilherme Santos-Junior; Eliot L Gardner; Josephine M Egan; Jeung Woon Lee; Zheng-Xiong Xi; Emmanuel S Onaivi
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

6.  Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.

Authors:  Marjolein Soethoudt; Uwe Grether; Jürgen Fingerle; Travis W Grim; Filomena Fezza; Luciano de Petrocellis; Christoph Ullmer; Benno Rothenhäusler; Camille Perret; Noortje van Gils; David Finlay; Christa MacDonald; Andrea Chicca; Marianela Dalghi Gens; Jordyn Stuart; Henk de Vries; Nicolina Mastrangelo; Lizi Xia; Georgios Alachouzos; Marc P Baggelaar; Andrea Martella; Elliot D Mock; Hui Deng; Laura H Heitman; Mark Connor; Vincenzo Di Marzo; Jürg Gertsch; Aron H Lichtman; Mauro Maccarrone; Pal Pacher; Michelle Glass; Mario van der Stelt
Journal:  Nat Commun       Date:  2017-01-03       Impact factor: 14.919

Review 7.  Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?

Authors:  Guido Cavaletti; Paola Marmiroli; Cynthia L Renn; Susan G Dorsey; Maria Pina Serra; Marina Quartu; Cristina Meregalli
Journal:  Neurotherapeutics       Date:  2021-10-19       Impact factor: 7.620

Review 8.  General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation.

Authors:  Mun Fei Yam; Yean Chun Loh; Chu Shan Tan; Siti Khadijah Adam; Nizar Abdul Manan; Rusliza Basir
Journal:  Int J Mol Sci       Date:  2018-07-24       Impact factor: 5.923

Review 9.  Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases.

Authors:  Dhanush Haspula; Michelle A Clark
Journal:  Int J Mol Sci       Date:  2020-10-17       Impact factor: 5.923

Review 10.  Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation.

Authors:  Nynke J van den Hoogen; Erika K Harding; Chloé E D Davidson; Tuan Trang
Journal:  Front Neural Circuits       Date:  2022-01-07       Impact factor: 3.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.